Australia - englanti - Department of Health (Therapeutic Goods Administration)

a vogel australia pty ltd - crataegus laevigata,crataegus monogyna -

Australia - englanti - Department of Health (Therapeutic Goods Administration)

a vogel australia pty ltd - cynara scolymus,mentha x piperita,peumus boldus,taraxacum officinale -

Yhdysvallat - englanti - NLM (National Library of Medicine)

alvogen inc. - methylphenidate hydrochloride (unii: 4b3sc438hi) (methylphenidate - unii:207zz9qz49) - methylphenidate hydrochloride 20 mg - attention deficit disorders (previously known as minimal brain dysfunction in children). other terms being used to describe the behavioral syndrome below include: hyperkinetic child syndrome, minimal brain damage, minimal cerebral dysfunction, minor cerebral dysfunction. methylphenidate hydrochloride extended-release tablets are indicated as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity. the diagnosis of this syndrome should not be made with finality when these symptoms are only of comparatively recent origin. nonlocalizing (soft) neurological signs, learning disability, and abnormal eeg may or may not be present, and a diagnosis of central nervous system dysfunction may or m

Australia - englanti - Department of Health (Therapeutic Goods Administration)

a vogel australia pty ltd - hedera helix, quantity: 400 mg/g (equivalent: hedera helix, qty 72 mg/g; equivalent: emetine, qty 50 ng/g); thymus vulgaris, quantity: 350 mg/g (equivalent: thymus vulgaris, qty 48.4 mg/g); glycyrrhiza glabra, quantity: 248.75 mg/g (equivalent: glycyrrhiza glabra, qty 24.87 mg/g); star anise oil, quantity: 0.5 microgram/g - oral liquid - excipient ingredients: eucalyptus oil - anti-inflammatory/relieve inflammation ; decrease/reduce/relieve mild bronchial irritation ; decrease/reduce/relieve bronchial mucous congestion ; decrease/reduce excess chest phlegm ; loosen chest phlegm ; decrease/reduce/relieve mild upper respiratory tract congestion ; decrease/reduce/relieve the severity of symptoms of mild upper respiratory tract infections ; helps soothe respiratory tract ; expectorant/clear respiratory tract mucous ; loosen respiratory tract mucous ; relieve symptoms of mild upper respiratory tract infections ; antitussive/cough suppressant ; decrease/reduce/relieve mild bronchial cough ; decrease/reduce/relieve cough ; enhance/improve/promote/increase cough productivity ; relieve symptoms of sore throat/pharyngitis

Kenia - englanti - Pharmacy and Poisons Board

micro labs limited no 27 , race course road - voglibose - tablet - 0.3mg - voglibose

Kenia - englanti - Pharmacy and Poisons Board

micro labs limited, india # 27, race course road bangalore – 560 001 - voglibose - tablet - 0.3mg - voglibose

Irlanti - englanti - HPRA (Health Products Regulatory Authority)

intervet ireland limited - leptospira interrogans serovar hardjo inactivated suspension - suspension for injection - unknown - leptospira vaccine - bovine - immunological - inactivated vaccine

Filippiinit - englanti - FDA (Food And Drug Administration)

n/a; importer: getz pharma (phils.), inc.; distributor: n/a - simvastatin - film-coated tablet - 40mg

Filippiinit - englanti - FDA (Food And Drug Administration)

getz pharma (phils.) inc. - simvastatin - film-coated tablet - 20mg

Filippiinit - englanti - FDA (Food And Drug Administration)

getz pharma (phils.), inc.; distributor: getz pharma (phils.), inc. - simvastatin - film-coated tablet - 10 mg